gamunex solution
grifols therapeutics llc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums
gamunex 10 % inf. sol. i.v. vial
grifols deutschland gmbh - human normal immunoglobulin 1 g/10 ml - solution for infusion - 10 % - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
gamunex 10 % inf. sol. i.v. vial
grifols deutschland gmbh - human normal immunoglobulin 1 g/10 ml - solution for infusion - 10 % - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
gamunex 10 % inf. sol. i.v. vial
grifols deutschland gmbh - human normal immunoglobulin 1 g/10 ml - solution for infusion - 10 % - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
gamunex 10 % inf. sol. i.v. vial
grifols deutschland gmbh - human normal immunoglobulin 1 g/10 ml - solution for infusion - 10 % - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
gamunex 10 % inf. sol. i.v. vial
grifols deutschland gmbh - human normal immunoglobulin 1 g/10 ml - solution for infusion - 10 % - human normal immunoglobulin 100 mg/ml - immunoglobulins, normal human, for intravascular adm.
gamunex-c (immune globulin- human injection
grifols usa, llc - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 10 g in 100 ml - gamunex-c is an immune globulin injection (human) 10% liquid that is indicated for the treatment of: gamunex-c is indicated for treatment of primary humoral immunodeficiency in patients 2 years of age and older. this includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, x-linked agammaglobulinemia, wiskott-aldrich syndrome, and severe combined immunodeficiencies.(1-4) gamunex-c is indicated for the treatment of adults and children with idiopathic thrombocytopenic purpura to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.(5,6) gamunex-c is indicated for the treatment of cidp in adults to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse. gamunex-c is contraindicated in patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. gamunex-c is contraindicated in iga deficient patients with antibodies against iga and history of h
gamunex
grifols australia pty ltd - immunoglobulin - normal; normal immunoglobulin (human); normal immunoglobulin (human) -
gammagard liquid solution
takeda canada inc - immunoglobulin (human) - solution - 10% - immunoglobulin (human) 10% - serums
xembify solution
grifols therapeutics llc - immunoglobulin (human) - solution - 20% - immunoglobulin (human) 20% - serums